All studies
CompletedInterventional

Testing tumour genetics in patients with cancers resistant to standard-of-care therapy

Standard cancer treatments do not work for everyone. When approved options run out, clinical trials testing new medicines can offer another path forward. Joining these trials often depends on the unique genetic features of a person's tumour. However, getting these detailed test results can currently take a long time. The IMAGINE study aims to cut this waiting time down to less than six weeks. Researchers at the Beatson West of Scotland Cancer Centre in Glasgow will collect blood samples and small tissue samples (biopsies) from patients with advanced cancer. They will test these samples to build a genetic profile of the tumour. While taking part may not change your treatment immediately, it helps doctors build a faster testing system. In the future, this could help patients access suitable, targeted clinical trials much sooner.

At a glance

Status
Completed
Sponsor
Greater Glasgow & Clyde NHS Board
Enrolment target
200
Start
07 Jan 2020
Estimated completion
30 Sep 2026

What is this study about?

Cancer care is moving toward personalised medicine. In the past, treatments were mainly chosen based on where cancer started in the body. Today, doctors know that every tumour has its own unique set of genes. By looking closely at these tumour genes, specialists can often find specific targets and match patients with treatments designed to attack those exact weaknesses.

For people whose cancer has returned or stopped responding to standard NHS treatments, early-phase clinical trials offer access to experimental therapies. Many of these trials accept patients with different types of cancer, as long as their tumours share the same genetic traits. However, finding these genetic traits requires specialised laboratory testing, which can currently take many weeks or months.

The IMAGINE study was created to fix this delay. Based at the Beatson West of Scotland Cancer Centre, the research team wants to speed up the testing process. Their goal is to return tumour test results within six weeks of a patient joining the study, and eventually make that turnaround even faster.

By taking part, you help doctors test and refine this faster system. The ultimate goal is to make sure future cancer patients can be matched with potentially life-extending clinical trials without unnecessary delays.

Key takeaways

  • The IMAGINE study aims to provide tumour genetic test results in under six weeks.
  • It is for adults with advanced solid cancers who have been referred to the Beatson trials clinic.
  • Participation involves routine blood tests and usually a fresh tumour biopsy.
  • If you already have genetic test results from another study or private care, you can share those instead.
  • Taking part helps doctors match future cancer patients to targeted clinical trials much faster.

Who may be eligible?

This study is designed for adults aged 18 and over who have an advanced solid tumour (cancer that forms a solid lump, rather than blood cancer). It is open to people who have already tried standard cancer treatments and have been referred to the early-phase clinical trials clinic at the Beatson West of Scotland Cancer Centre in Glasgow.

To join, you must be well enough to receive further cancer treatments. You will also need to be fit and willing to have a fresh biopsy, which is a small procedure to take a tiny sample of tumour tissue for testing.

If you cannot have a biopsy or prefer not to have one, you might still be able to join if your tumour has already had detailed genetic testing done through private care or as part of another trial.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I have been diagnosed with an advanced solid cancer.
  3. I have been referred to the early-phase trials clinic at the Beatson West of Scotland Cancer Centre.
  4. I am well enough to receive further cancer treatments.
  5. I am willing and able to have a tumour biopsy, OR I already have recent genetic test results available.
Answer every question to see your result.

What does participation involve?

If you take part, the study team will first look at tumour samples kept from your original diagnosis or past surgeries. Most participants will then have a new biopsy taken from an area where the cancer is currently active. During a biopsy, a doctor uses local anaesthetic to numb the area and uses an ultrasound or CT scanner to guide a thin needle into the tumour. The procedure might require a few small stitches that come out after several days.

You will also give routine blood samples. The team will take up to 30 millilitres of blood (about six teaspoons) to look for cancer DNA and inherited gene changes. If an inherited gene is found, doctors will do a standard clinical test to confirm it.

If you go on to receive a new cancer treatment, the team may ask for extra blood tests before your first two doses, as well as an optional second biopsy if your cancer changes. You can say no to these extra tests at any time without leaving the main study. If you already have existing genetic results, you simply give permission for your data to be added to the study database.

Potential risks and benefits

Taking part may not directly cure or shrink your cancer, and early in the study, test results might not come back fast enough to guide your personal treatment. However, you will receive close care and regular monitoring from a specialist cancer research team. The main physical risks relate to the biopsy, which can cause temporary soreness, bruising, light bleeding, or rarely, a minor infection at the needle site. Blood tests can cause brief discomfort or mild bruising. Joining the study is completely up to you, and you are free to withdraw at any time without affecting your normal NHS medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Beatson West of Scotland Cancer Centre
    City only
    Glasgow, Scotland

Common questions

Will taking part in this study change my cancer treatment?

Not right away. The main purpose of this study is to test and speed up the testing process itself. In the future, the results may help your care team find clinical trials that suit your specific cancer.

Does having a biopsy hurt?

You will be given a local anaesthetic to numb the skin and tissue first. You might feel some pressure or brief stinging, and the area may feel bruised or tender for a few days afterwards.

What happens if you find an inherited gene change?

If researchers spot a gene change that might have been passed down from your parents, they will run a formal confirmatory test in a clinical laboratory and discuss what the result means for you and your family.

Can I say no to the second biopsy or extra blood tests?

Yes. Any additional biopsies or extra blood tests after you start a new treatment are completely optional. You can say no to them and remain in the main study.

Where does the study take place?

The study takes place at the Beatson West of Scotland Cancer Centre in Glasgow, supported by NHS Greater Glasgow and Clyde.

How to find out more

Ann Shaw

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.